Olaris, Inc.
PrivateLast Round
Series B
Extension
Apr 8, 2025
Total Funding Raised
$62,500
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Olaris, Inc. is a biotechnology company that develops precision diagnostics by integrating metabolomics and machine learning to identify metabolite signatures for clinical decision-making.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Healthcare Analytics, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Olaris, Inc. Comparables
Compare Olaris, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Verici Dx plc | 77% | |
| Eurofins Scientific SE | 74% | |
| CareDx | 73% | |
Olaris, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Apr 8, 2025 | ||||
| Grant | Feb 11, 2020 | ||||
| Series A | Jun 20, 2019 | ||||
| Grant | Jun 20, 2018 |
Key People
Founding team and executive leadership
Olaris, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pear Tree Partners | Series B Extension |
| Massachusetts Life Sciences Center | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| InnoSpark Ventures | Series B Extension, Series A |
| Alumni Ventures | Series B Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 25, 2026
Grew 19% QoQ, from 16 to 19 employees.
- Apr 29, 2026
Grew 20% QoQ, from 15 to 18 employees.
Olaris, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Olaris, Inc.'s valuation, stock price, and market status.